// App-Quantinova.ai

320 : Teriparatide Compared with Risedronate and the Risk of Clinical Vertebral Fractures: 2-Year Results of a Randomized, Double-Dummy Clinical Trial

Researchers

Presenter

  • Cristiano A.F Zerbini

Principal Investigators

  • Piet Geusens

  • Eric Lespessailles

  • Jean-Jacques Body

  • Enrique Casado

  • Jan Stepan

  • David L Kendler

  • Luis Russo

  • Susan L. Greenspan

  • Salvatore Minisola

  • Alicia Bagur

  • Peter Lakatos

  • Astrid Fahrleitner-Pammer

  • Rdiger Mricke

  • Pedro Lopez-Romero

  • Fernando Marin

Medical Centers

  • Centro Paulista de Investigacoe s Clinicas, Sao Paulo, Brazil

  • Maastricht University, Maastricht, Netherlands

  • Servcie d?Hematologie, CHR Orleans, Orleans, France

  • CHU Brugmann, Free University Brussels, Brussels, Belgium

  • Rheumatology, Hospital Parc Tauli, Sabadell, Spain

  • Institute of Rheumatology, st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic

  • The University of British Columbia, Vancouver, BC, Canada

  • Centro de Analises e Pesquisas Clínicas LTDA,, Rio de Janeiro, Brazil

  • University of Pittsburgh, Pittsburgh, PA

  • Internal Medicine, Policlinico Umberto I,, Rome, Italy

  • Centro de Osteopatias Medicas, Buenos Aires, Argentina

  • First Department of Internal Medicine, Semmelweis University, Budapest, Hungary

  • Division of Oncology, Medical University of Graz, Graz, Austria

  • Institut fur Praventive Medizin & Klinische Forschung GbR, Magdeburg, Germany

  • Europe Research Center, Eli Lilly and Company, Madrid, Spain

  • Lilly Research Center Europe, Madrid, Spain

Locations

  • Brazil

  • Netherlands

  • France

  • Belgium

  • Spain

  • Czech Republic

  • Canada

  • United States

  • Italy

  • Argentina

  • Hungary

  • Austria

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Teriparatide

  • Risedronate sodium

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved